Drugmakers Compete for Share in Expanding Obesity Drug Market

Pharmaceutical companies are intensifying efforts to enter the lucrative obesity drug market, currently dominated by Novo Nordisk and Eli Lilly, as they seek to develop the next generation of treatments.